Literature DB >> 26779608

Simplified conversion method for unified Parkinson's disease rating scale motor examinations.

Joseph G Hentz1, Shyamal H Mehta2, Holly A Shill3, Erika Driver-Dunckley2, Thomas G Beach4, Charles H Adler2.   

Abstract

BACKGROUND: We evaluated a simplified method for converting Unified Parkinson's Disease Rating Scale Part III Motor Examination total scores (UPDRS III) to the International Parkinson and Movement Disorder Society's (MDS) revised version of the scores.
METHODS: PD patients in the Arizona Study of Aging and Neurodegenerative Disorders were assessed with both scales. The accuracy of the predicted scores was assessed using regression modeling, classical intraclass correlation coefficients, and the Bland-Altman method.
RESULTS: There was strong correlation between the two scores. Adding 7 points to a UPDRS III total score performed approximately as well as previously published conversion formulas (intraclass correlation: 0.96). The adjusted score is expected to be within 3 points of the MDS-UPDRS III score 50% of the time and within 9 points 95% of the time.
CONCLUSIONS: Simply adding 7 points to a UPDRS III total score provides a good approximation of the MDS-UPDRS III total score.
© 2015 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  MDS; Parkinson's; UPDRS; motor; score

Mesh:

Year:  2015        PMID: 26779608      PMCID: PMC4717915          DOI: 10.1002/mds.26435

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  5 in total

1.  Correlation between the Movement Disorders Society Unified Parkinson's Disease rating scale (MDS-UPDRS) and the Unified Parkinson's Disease rating scale (UPDRS) during L-dopa acute challenge.

Authors:  Marcelo Merello; Eliana Roldan Gerschcovich; Diego Ballesteros; Daniel Cerquetti
Journal:  Parkinsonism Relat Disord       Date:  2011-07-23       Impact factor: 4.891

2.  Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.

Authors:  Thomas G Beach; Charles H Adler; Lucia I Sue; Geidy Serrano; Holly A Shill; Douglas G Walker; LihFen Lue; Alex E Roher; Brittany N Dugger; Chera Maarouf; Alex C Birdsill; Anthony Intorcia; Megan Saxon-Labelle; Joel Pullen; Alexander Scroggins; Jessica Filon; Sarah Scott; Brittany Hoffman; Angelica Garcia; John N Caviness; Joseph G Hentz; Erika Driver-Dunckley; Sandra A Jacobson; Kathryn J Davis; Christine M Belden; Kathy E Long; Michael Malek-Ahmadi; Jessica J Powell; Lisa D Gale; Lisa R Nicholson; Richard J Caselli; Bryan K Woodruff; Steven Z Rapscak; Geoffrey L Ahern; Jiong Shi; Anna D Burke; Eric M Reiman; Marwan N Sabbagh
Journal:  Neuropathology       Date:  2015-01-26       Impact factor: 1.906

3.  Calibration of unified Parkinson's disease rating scale scores to Movement Disorder Society-unified Parkinson's disease rating scale scores.

Authors:  Christopher G Goetz; Glenn T Stebbins; Barbara C Tilley
Journal:  Mov Disord       Date:  2012-08-06       Impact factor: 10.338

4.  Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study.

Authors:  Charles H Adler; Thomas G Beach; Joseph G Hentz; Holly A Shill; John N Caviness; Erika Driver-Dunckley; Marwan N Sabbagh; Lucia I Sue; Sandra A Jacobson; Christine M Belden; Brittany N Dugger
Journal:  Neurology       Date:  2014-06-27       Impact factor: 9.910

5.  Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

Authors:  Christopher G Goetz; Barbara C Tilley; Stephanie R Shaftman; Glenn T Stebbins; Stanley Fahn; Pablo Martinez-Martin; Werner Poewe; Cristina Sampaio; Matthew B Stern; Richard Dodel; Bruno Dubois; Robert Holloway; Joseph Jankovic; Jaime Kulisevsky; Anthony E Lang; Andrew Lees; Sue Leurgans; Peter A LeWitt; David Nyenhuis; C Warren Olanow; Olivier Rascol; Anette Schrag; Jeanne A Teresi; Jacobus J van Hilten; Nancy LaPelle
Journal:  Mov Disord       Date:  2008-11-15       Impact factor: 10.338

  5 in total
  14 in total

Review 1.  Interventions for preventing falls in Parkinson's disease.

Authors:  Natalie E Allen; Colleen G Canning; Lorena Rosa S Almeida; Bastiaan R Bloem; Samyra Hj Keus; Niklas Löfgren; Alice Nieuwboer; Geert Saf Verheyden; Tiê P Yamato; Catherine Sherrington
Journal:  Cochrane Database Syst Rev       Date:  2022-06-06

2.  Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers.

Authors:  Gian Pal; Graziella Mangone; Emily J Hill; Bichun Ouyang; Yuanqing Liu; Vanessa Lythe; Debra Ehrlich; Rachel Saunders-Pullman; Vicki Shanker; Susan Bressman; Roy N Alcalay; Priscilla Garcia; Karen S Marder; Jan Aasly; M Maral Mouradian; Samantha Link; Marc Rosenbaum; Sharlet Anderson; Bryan Bernard; Robert Wilson; Glenn Stebbins; William C Nichols; Marie-Laure Welter; Sepehr Sani; Mitra Afshari; Leo Verhagen; Rob M A de Bie; Tom Foltynie; Deborah Hall; Jean-Christophe Corvol; Christopher G Goetz
Journal:  Ann Neurol       Date:  2022-01-25       Impact factor: 11.274

3.  Multiculturalism: A Challenge for Cognitive Screeners in Parkinson's Disease.

Authors:  Marta Statucka; Kirsten Cherian; Alfonso Fasano; Renato P Munhoz; Melanie Cohn
Journal:  Mov Disord Clin Pract       Date:  2021-05-27

4.  Sensor-based gait analysis in atypical parkinsonian disorders.

Authors:  Cecilia Raccagni; Heiko Gaßner; Sabine Eschlboeck; Sylvia Boesch; Florian Krismer; Klaus Seppi; Werner Poewe; Bjoern M Eskofier; Juergen Winkler; Gregor Wenning; Jochen Klucken
Journal:  Brain Behav       Date:  2018-05-07       Impact factor: 2.708

5.  Striatal shape alteration as a staging biomarker for Parkinson's Disease.

Authors:  Maxime Peralta; John S H Baxter; Ali R Khan; Claire Haegelen; Pierre Jannin
Journal:  Neuroimage Clin       Date:  2020-05-19       Impact factor: 4.881

6.  Origins Matter: Culture Impacts Cognitive Testing in Parkinson's Disease.

Authors:  Marta Statucka; Melanie Cohn
Journal:  Front Hum Neurosci       Date:  2019-08-08       Impact factor: 3.169

7.  Prediction of the Levodopa Challenge Test in Parkinson's Disease Using Data from a Wrist-Worn Sensor.

Authors:  Hamid Khodakarami; Lucia Ricciardi; Maria Fiorella Contarino; Rajesh Pahwa; Kelly E Lyons; Victor J Geraedts; Francesca Morgante; Alison Leake; Dominic Paviour; Andrea De Angelis; Malcolm Horne
Journal:  Sensors (Basel)       Date:  2019-11-25       Impact factor: 3.576

8.  α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophy.

Authors:  Suman Dutta; Simon Hornung; Adira Kruayatidee; Katherine N Maina; Irish Del Rosario; Kimberly C Paul; Darice Y Wong; Aline Duarte Folle; Daniela Markovic; Jose-Alberto Palma; Geidy E Serrano; Charles H Adler; Susan L Perlman; Wayne W Poon; Un Jung Kang; Roy N Alcalay; Miriam Sklerov; Karen H Gylys; Horacio Kaufmann; Brent L Fogel; Jeff M Bronstein; Beate Ritz; Gal Bitan
Journal:  Acta Neuropathol       Date:  2021-05-15       Impact factor: 15.887

9.  Baseline concentration of misfolded α-synuclein aggregates in cerebrospinal fluid predicts risk of cognitive decline in Parkinson's disease.

Authors:  H Ning; Q Wu; D Han; T Yao; J Wang; W Lu; S Lv; Q Jia; X Li
Journal:  Neuropathol Appl Neurobiol       Date:  2018-11-15       Impact factor: 8.090

10.  Identification of sixteen novel candidate genes for late onset Parkinson's disease.

Authors:  Alessandro Gialluisi; Mafalda Giovanna Reccia; Nicola Modugno; Teresa Nutile; Alessia Lombardi; Luca Giovanni Di Giovannantonio; Sara Pietracupa; Daniela Ruggiero; Simona Scala; Stefano Gambardella; Licia Iacoviello; Fernando Gianfrancesco; Dario Acampora; Maurizio D'Esposito; Antonio Simeone; Marina Ciullo; Teresa Esposito
Journal:  Mol Neurodegener       Date:  2021-06-21       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.